Marketing-authorisation holder · United States
Pharmobedient
58 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 58
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABACAVIR SULFATE AND LAMIVUDINE60mg base; 30mg · Tablet, for suspension | Abacavir, Lamivudine | United States | Not marketed | 2023 |
| ACCUNEB0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Salbutamol | United States | Not marketed | 2001 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE120mg/5ml; 12mg/5ml · Solution | Paracetamol, Codeine | United States | Marketed | 1978 |
| ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE325mg; 30mg; 16mg · Tablet | Paracetamol, Caffeine, Dihydrocodeine | United States | Not marketed | 2016 |
| AEROSPAN HFA0.078mg/inh · Aerosol, metered | Flunisolide | United States | Not marketed | 2006 |
| ALLZITAL325mg; 25mg · Tablet | Paracetamol, Butalbital | United States | Marketed | 2015 |
| AMIODARONE HYDROCHLORIDE100mg | 200mg | 300mg | 400mg · Tablet | Amiodarone | United States | Marketed | 1998 |
| ANADROL-5050mg · Tablet | Oxymetholone | United States | Not marketed | 1972 |
| AVC1.05gm · Suppository | Sulfanilamide | United States | Not marketed | 1965 |
| AVC15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Cream | Sulfanilamide | United States | Not marketed | 1965 |
| AZITHROMYCIN2.5gm base/vial | 500mg base/vial · Injectable | Azithromycin | United States | Marketed | 2005 |
| BACLOFEN10mg | 15mg | 20mg | 5mg · Tablet | Baclofen | United States | Marketed | 1988 |
| BUTISOL SODIUM100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 30MG | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Butabarbital | United States | Not marketed | 1939 |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE16mg; 12.5mg | 32mg; 12.5mg | 32mg; 25mg · Tablet | Candesartan cilexetil, Hydrochlorothiazide | United States | Marketed | 2012 |
| CHLOROTHIAZIDE-RESERPINE250mg; 0.125mg | 500mg; 0.125mg · Tablet | Chlorothiazide, Reserpine | United States | Not marketed | 1982 |
| CIPROFLOXACIN HYDROCHLORIDE0.3% base · Solution/drops | Ciprofloxacin | United States | Marketed | 2004 |
| COSYNTROPIN0.25mg/vial · Injectable | Cosyntropin | United States | Marketed | 2009 |
| DEFERASIROX180mg | 360mg | 90mg · Granule | Deferasirox | United States | Marketed | 2020 |
| DEMADEX100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register d · Tablet | Torasemide | United States | Not marketed | 1993 |
| DUONEB0.083% BASE; 0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Salbutamol, Ipratropium bromide | United States | Not marketed | 2001 |
| DUTASTERIDE0.5mg · Capsule | Dutasteride | United States | Marketed | 2010 |
| E-GLADES2% · GEL | Erythromycin | United States | Not marketed | 2002 |
| ENLON10mg/ml · Injectable | Edrophonium | United States | Not marketed | 1985 |
| ENLON-PLUS0.14mg/ml; 10mg/ml · Injectable | Atropine, Edrophonium | United States | Not marketed | 1991 |
| ENTACAPONE200mg · Tablet | Entacapone | United States | Marketed | 2012 |